Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 November 2008, Vol. 112, No. 9, pp. 3601-3614.
Prepublished online as a Blood First Edition Paper on September 5, 2008; DOI 10.1182/blood-2008-03-144766.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Methods, Tables, and Figures
Right arrow All Versions of this Article:
blood-2008-03-144766v1
blood-2008-03-144766v2
112/9/3601    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zambidis, E. T.
Right arrow Articles by Péault, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zambidis, E. T.
Right arrow Articles by Péault, B.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

HEMATOPOIESIS AND STEM CELLS

Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells

Elias T. Zambidis1,2, Tea Soon Park3, Wayne Yu2, Ada Tam1, Michal Levine1, Xuan Yuan1,2, Marina Pryzhkova1, and Bruno Péault3

1 Institute of Cell Engineering, Stem Cell Program, Johns Hopkins University School of Medicine, and 2 Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; and 3 Stem Cell Research Center, Department of Pediatrics, McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, PA

We report that angiotensin-converting enzyme (ACE), a critical physiologic regulator of blood pressure, angiogenesis, and inflammation, is a novel marker for identifying hemangioblasts differentiating from human embryonic stem cells (hESC). We demonstrate that ACE+CD45CD34+/– hemangioblasts are common yolk sac (YS)–like progenitors for not only endothelium but also both primitive and definitive human lymphohematopoietic cells. Thrombopoietin and basic fibroblast growth factor are identified as critical factors for the proliferation of human hemangioblasts. The developmental sequence of human embryoid body hematopoiesis is remarkably congruent to the timeline of normal human YS development, which occurs during weeks 2 to 6 of human gestation. Furthermore, ACE and the renin-angiotensin system (RAS) directly regulate hemangioblast expansion and differentiation via signaling through the angiotensin II receptors AGTR1 and AGTR2. ACE enzymatic activity is required for hemangioblast expansion, and differentiation toward either endothelium or multipotent hematopoietic progenitors is dramatically augmented after manipulation of angiotensin II signaling with either AGTR1- or AGTR2-specific inhibitors. The RAS can therefore be exploited to direct the hematopoietic or endothelial fate of hESC-derived hemangioblasts, thus providing novel opportunities for human tissue engineering. Moreover, the initial events of human hematoendotheliogenesis can be delineated in a manner previously impossible because of inaccessibility to early human embryonic tissues.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
D. S. Kaufman
Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells
Blood, October 22, 2009; 114(17): 3513 - 3523.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Graziano, S. Carone, E. Panza, F. Marino, P. Magini, G. Romeo, A. Pession, and M. Seri
Association of hereditary thrombocythemia and distal limb defects with a thrombopoietin gene mutation
Blood, August 20, 2009; 114(8): 1655 - 1657.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
T. S. Park and E. T. Zambidis
A role for the renin-angiotensin system in hematopoiesis
Haematologica, June 1, 2009; 94(6): 745 - 747.
[Full Text] [PDF]


Home page
haematolHome page
S. Heringer-Walther, K. Eckert, S.-M. Schumacher, L. Uharek, A. Wulf-Goldenberg, F. Gembardt, I. Fichtner, H.-P. Schultheiss, K. Rodgers, and T. Walther
Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo
Haematologica, June 1, 2009; 94(6): 857 - 860.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020